Skip to content
Live funding
Sesame Summit 2027
Sesamers
← Startups directory

Prevision Medicine

Seed · Zurich, Switzerland

Prevision Medicine is a Zurich-based precision oncology company whose functional testing platform evaluates a patient's living tumour-derived cells against a treatment library to guide personalised cancer treatment decisions.

This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.

€4,750,000
Total raised
-
Valuation
-
Employees
2024
Founded

Latest round

Seed - September 24, 2026
GoHub Ventures, SICTIC, angel investors focused on oncology and precision medicine. Announced as USD 5,400,000 seed, 24 Sep 2026; EUR 4.75M stored per the scout's conversion. Lead: ACE Ventures (Swiss early-stage VC). Corroborated by the company announcement (previsionmedicine.com), Startupticker (24 Sep) and Tech Startups (25 Sep); lead named consistently. Company: Zurich (Schlieren HQ, lab at ETH Hoenggerberg, office at Biopole Startlab, Epalinges), founded 2024, CEO Philip Zimmermann.

✓ verified by our desk

Open roles

Prevision Medicine is not hiring through Sesamers right now.

Work here? Claim the profile and post roles.

Claim your profile
Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.